Early administration of IV heparin improves coronary patencyLewis lung carcinoma cells were implanted in the foot-pads of mice and the effects of the plasminogen-plasmin inhibitor tranexamic acid (t-AMCHA) and of the plasminogen activator urokinase on metastasis were examined by electron microscopy. ...
Nursing interventions can and should occur during the administration of heparin, through the teaching of patients on heparin treatment, and through the monitoring and awareness of the precautions with heparin treatment. What test is prescribed to monitor heparin's effects? The therapeutic range of ...
To test the seeding potential of apo-α-syn PFFs and heparin-α-syn PFFs to endogenous α-syn, a previously published protocol was adopted61,62. Briefly, equal volumes of Lipofectamine-2000 (Invitrogen) and α-syn PFFs solutions, both diluted in Neurobasal Medium (Thermo Fisher) without B27...
The major advantages of using heparin are its low cost, ease of administration, monitoring, and reversibility. However, the increased risks for bleeding with heparin use is a major concern in critically-ill children who are predisposed to bleeding for many reasons such as surgical procedures, ...
Three therapeutic approaches have been used: (1) alternative insulin administration routes (IV, IM, or intraperitoneal), (2) protease inhibitors to prevent enzymatic degradation of insulin (aprotinin) (6), and (3) additives co-administered with insulin to facilitate rapid absorption at the ...
Administration of 0.1 to 0.2 mg of intracoronary nitroglycerin preceded angiographic runs acquired for QCA analysis. Calibration was performed on the contrast-filled catheter. The lesions were analyzed by the worst-view approach. The BA ratio was calculated from the ratio of the largest inflated RD ...
(international normalized ratio >2 times upper limit of normal or activated partial thromboplastin time >2 times the upper limit of normal), severe thrombocytopenia (platelet count <75 × 109/L), need for therapeutic anticoagulation, heparin administration in the ICU for at least 3 days, ...
[0077] The t-PA variants of the present invention are typically administered as a single (occasionally repeated) intravenous (IV) bolus, in combination with a low molecular weight heparin, which is typically administered intravenously and/or subcutaneously (SC). Bolus administration has several advant...
Most of the literature on heparin use in acute ischemic stroke does not describe dose-adjusted intravenous unfractionated heparin (IV UFH) without bolus, a common method of administration. This study was designed to test whether an anticoagulation regimen of intravenous dose-adjusted UFH with no ...
(mean ± SD) and GA 28 ± 3 wk, were treated with heparin (1 U/ml) containing IV fluids infused into the umbilical artery and 23 control infants, BW 1,001 ± 416 g and GA 28 ± 3 wk were managed in an identical manner but without the administration of heparinized fluids during ...